Holding(s) in Company

Allergy Therapeutics PLC
06 February 2007

Allergy Therapeutics plc



Holding in Company



Allergy Therapeutics plc (the "Company") received notification on 2 February
2007 from AXA Investment Managers UK Ltd that AXA S.A. and its group companies
are interested in 5,779,620 ordinary shares of 0.1 pence each ("Ordinary Shares
"), comprising a beneficial interest of 2,400,000 Ordinary Shares and a
non-beneficial interest of 3,379,620 Ordinary Shares, representing 7.05 per
cent. of the Company's issued share capital of 81,950,632 Ordinary Shares, as
detailed below:




Company / Fund                                                  Holding              %
AXA Framlington Xerox Final Salary Pension Scheme               447,250              0.55

(Non-beneficial)
AXA Framlington Islington Group Pension Scheme                  280,832              0.34

(Non-beneficial)
AXA Framlington SEI UK Equity                                   500,000              0.61

(Non-beneficial)
AXA Framlington Throgmorton Trust                               2,400,000            2.93

(Beneficial)
AXA Framlington UK Smaller Companies                            1,400,000            1.71

(Non-beneficial)
AXA Framlington Biotech                                         283,200              0.35

(Non-beneficial)
AXA Framlington BAE Systems Pensions Fund CIF Trustees          325,644              0.40

(Non-beneficial)
AXA Framlington BAE Systems 2000 Pensions Fund                  142,694              0.17

(Non-beneficial)

Total                                                           5,779,620            7.05%




                      This information is provided by RNS
            The company news service from the London Stock Exchange